Breaking News Instant updates and real-time market news.

GM

General Motors

$37.32

-0.37 (-0.98%)

08:47
08/29/18
08/29
08:47
08/29/18
08:47

GM postpones launch of Buick EV in China due to battery issues, WSJ reports

General Motors' plans to accelerate electric-vehicle production in China were set back after the company found that the Chinese-made batteries it intended to use failed to meet its own performance and safety standards during testing, the Wall Street Journal reports, citing a person familiar with the situation. GM, which still plans to launch 10 EVs in China by 2020, was intending to enter production next month on its plug-in hybrid Buick Velite 6, with a pure-electric model due to follow next year, but that launch schedule has now been delayed with internal tests showing the battery did not meet quality standards. Reference Link

  • 31

    Aug

GM General Motors
$37.32

-0.37 (-0.98%)

07/20/18
07/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS YUM CHINA TO UNDERPERFORM: BofA Merrill Lynch analyst Chen Luo downgraded Yum China (YUMC) to Underperform from Neutral and cut its price target to $34 from $44.30. Luo said he expects Yum China to continue to underperform given a likely peak in KFC trends amid China's weakening macro environment, a likely prolonged turnaround at Pizza Hut combined with heavy costs, a slowdown in Chinese consumer consumption, and RMB depreciation. Yum China is down 4.8% in late morning trading. CREDIT SUISSE CUTS FIVE BELOW TO NEUTRAL: Credit Suisse analyst Judah Frommer downgraded Five Below (FIVE) to Neutral from Outperform, telling investors that he is moving to the sidelines as he sees risk/reward balanced at current levels given the stock's material outperformance and back-half comp acceleration that he believes is priced into shares. Frommer keeps his $110 price target and says Five Below remains one of the most differentiated concepts in retail. Five Below is down 4.4% in late morning trading. BAIRD MORE CAUTIOUS ON DRUG SUPPLY CHAIN: Baird analyst Eric Coldwell downgraded Express Scripts (ESRX), AmerisourceBergen (ABC), and McKesson (MCK), all to Neutral from Outperform, citing the heavy political attack in recent weeks against pharmacy benefit managers and members of the drug supply chain. Among them, he said AmerisourceBergen remains his preferred name, but he cannot justify putting new money to work in these names in the current environment. SUNTRUST STARTS VIKING WITH A BUY: SunTrust analyst Edward Nash initiated Viking Therapeutics (VKTX) with a Buy rating and a price target of $14, saying its VK2809 drug for lipid disorders "has the potential to become a promising treatment by addressing multiple metabolic issues" associated with the non-alcoholic steatohepatitis disease, or NASH. Viking is up 8.3% in late morning trading. JPMORGAN SAYS BUY GM, SELL TESLA INTO EARNINGS: JPMorgan analyst Ryan Brinkman forecast lower than consensus Q2 earnings for Ford (F) and higher than consensus earnings for General Motors (GM). The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla (TSLA) in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintained Overweight ratings on GM and Ford, with a preference for GM shares. He also kept his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $57
PIPR
Overweight
General Motors outperforming Ford in China, says Piper Jaffray
While both would suffer in a trade war, it is clear that General Motors (GM) is outperforming Ford (F) in China, Piper Jaffray analyst Alexander Potter tells investors in a research note. The analyst views GM's China business as stable, with a growing presence in luxury. He thinks Cadillac represented 16.7% of GM's Q2 revenue in China, versus 13.6% in 2017, which should boost margins. Until its "new product blitz gains momentum, Ford's China business will likely continue bleeding," Potter contends. He notes the company's Ford's retail sales in China declined by 38% year-over-year in June. The analyst keeps an Overweight rating on GM and a Neutral rating on Ford.
07/26/18
SBSH
07/26/18
NO CHANGE
Target $60
SBSH
Buy
General Motors price target lowered to $60 from $70 at Citi
Citi analyst Itay Michaeli lowered his price target for General Motors to $60 citing worse currency and commodity headwinds following yesterday's Q2 results. The analyst keeps a Buy rating on the shares. GM's guidance, while disappointing, doesn't signal a change to the core thesis around pickup truck and robotaxi networks, Michaeli tells investors in a research note.
08/23/18
UBSW
08/23/18
NO CHANGE
UBSW
UBS teardown finds 'numerous' quality issues with Tesla's Model 3
The UBS Evidence Lab tore down the new Tesla (TSLA) Model 3, the 2014 BMW (BMWYY) i3, and 2017 Chevy Bolt from General Motors (GM), UBS analysts led by Colin Langan tell investors in a research note. While Tesla won the first test focused on powertrain and the second test focused on electronics, it came in last on the third test, which focused on fit and finish. Teardown experts noted "numerous" Model 3 quality issues including inconsistent gaps and flushness throughout the car, missing bolts, loose tolerances, and uneven and misaligned spot welds, UBS writes in a research note partially titled "The Revolution is Over." The Model 3 car scored "below average" on the firm's fit and finish quality audit. The results confirm media reports of quality issues and are disappointing for a $49,000 car, UBS writes to investors. The winner of the third test was the Chevy Bolt, with the BMW i3 close behind. UBS believes the Bolt offers good value with a price that's over $10,000 lower than the BMW i3.

TODAY'S FREE FLY STORIES

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:03
12/18/18
12/18
06:03
12/18/18
06:03
Hot Stocks
Luxfer to acquire Neo Performance Materials for $612M in cash and stock »

Luxfer Holdings and Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
J&J CEO Alex Gorsky: 'We know our talc is safe,' 'does not cause cancer' »

Johnson & Johnson CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

TPC

Tutor Perini

$16.63

-0.08 (-0.48%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
Tutor Perini subsidiary awarded $104M contract by Royal Saudi Air Force »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$75.17

-2.54 (-3.27%)

06:01
12/18/18
12/18
06:01
12/18/18
06:01
Initiation
Copa Holdings initiated  »

Copa Holdings reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Hot Stocks
Breaking Hot Stocks news story on Luxfer »

Luxfer to acquire Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.69

-0.35 (-4.97%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Initiation
Adecogro initiated  »

Adecogro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$348.30

-17.39 (-4.76%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
Musk's Boring Co. faces concerns over diversion of SpaceX resources, WSJ says »

Elon Musk's the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
J&J looks to contain fallout from baby powder report with ads, Reuters reports »

Johnson & Johnson on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

EFX

Equifax

$97.25

0.06 (0.06%)

05:55
12/18/18
12/18
05:55
12/18/18
05:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

UNCFF

UniCredit

$0.00

(0.00%)

05:53
12/18/18
12/18
05:53
12/18/18
05:53
Hot Stocks
Italy's UniCredit settles dispute with Caius »

On August 6, UniCredit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLC

Taiwan Liposome

$6.01

(0.00%)

05:52
12/18/18
12/18
05:52
12/18/18
05:52
Hot Stocks
Taiwan Liposome announces full enrollment of TLC590 Phase I/II clinical trial »

Taiwan Liposome announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$207.01

-8.57 (-3.98%)

, INGN

Inogen

$125.96

-4.85 (-3.71%)

05:48
12/18/18
12/18
05:48
12/18/18
05:48
Recommendations
Align Technology, Inogen, Nuvectra, Intuitive Surgical, Merit Medical analyst commentary  »

Piper lays out top…

ALGN

Align Technology

$207.01

-8.57 (-3.98%)

INGN

Inogen

$125.96

-4.85 (-3.71%)

NVTR

Nuvectra

$16.27

-0.38 (-2.28%)

ISRG

Intuitive Surgical

$481.95

-9.89 (-2.01%)

MMSI

Merit Medical

$54.54

-1.79 (-3.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

ACHV

Achieve Life Sciences

$1.37

-0.07 (-4.86%)

05:45
12/18/18
12/18
05:45
12/18/18
05:45
Hot Stocks
Achieve Life Sciences: FDA confirms agreement with Initial Pediatric Study Plan »

Achieve Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MANU

Manchester United

$17.30

-0.2 (-1.14%)

05:39
12/18/18
12/18
05:39
12/18/18
05:39
Hot Stocks
Manchester United announces departure of manager Jose Mourinho »

Manchester United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$255.12

-5.49 (-2.11%)

05:39
12/18/18
12/18
05:39
12/18/18
05:39
Periodicals
Ex-official thinks U.S., China can reach trade deal in 90 days, SCMP reports »

Zhu Min, who was deputy…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$255.12

-5.49 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGA

Magna

$44.31

-1 (-2.21%)

05:38
12/18/18
12/18
05:38
12/18/18
05:38
Hot Stocks
Magna acquires VIZA Geca, terms not disclosed »

Magna signed an agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$6.05

-0.08 (-1.31%)

05:36
12/18/18
12/18
05:36
12/18/18
05:36
Hot Stocks
RYB Education announces $12M share repurchase program »

RYB Education announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$45.72

-0.9 (-1.93%)

05:32
12/18/18
12/18
05:32
12/18/18
05:32
Recommendations
Oracle analyst commentary  »

Oracle Q2 results a step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$85.19

-1.3 (-1.50%)

05:30
12/18/18
12/18
05:30
12/18/18
05:30
Hot Stocks
Nasdaq raises offer for proposed acquisition of Cinnober to SEK 87 per share »

On September 14, Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRH

DiamondRock

$9.58

-0.33 (-3.33%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Downgrade
DiamondRock rating change  »

DiamondRock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YNDX

Yandex

$27.49

-0.52 (-1.86%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Hot Stocks
Yandex to acquire property site for new Moscow headquarters »

Yandex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHO

Sunstone Hotel

$14.08

-0.32 (-2.22%)

05:23
12/18/18
12/18
05:23
12/18/18
05:23
Downgrade
Sunstone Hotel rating change  »

Sunstone Hotel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.31

-0.46 (-2.59%)

05:21
12/18/18
12/18
05:21
12/18/18
05:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

, S

Sprint

$5.83

-0.14 (-2.35%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Hot Stocks
T-Mobile, Sprint receives approval from CFIUS, Team Telecom »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

S

Sprint

$5.83

-0.14 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$5.76

-0.38 (-6.19%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Downgrade
Washington Prime rating change  »

Washington Prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.